Roche Seems Increasingly Confident in Obesity Portfolio — Market Talk
Roche Holding's confidence in its portfolio of medicines for obesity and diabetes seems to be growing as the Swiss drugmaker seeks an expansion into broader cardiovascular indications, UBS analysts say in a research note. "Management continues to expect a highly segmented obesity market, with orals…